Passage Bio, Inc. (PASG)
4.52
+0.19
(+4.39%)
USD |
NASDAQ |
Aug 28, 16:00
4.57
+0.05
(+1.11%)
After-Hours: 20:00
Passage Bio Price : 4.52 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 4.32 | 4.60 | 4.31 | 4.52 | 21893.00 |
| Aug 27, 2026 | 4.46 | 4.53 | 4.31 | 4.33 | 13961.00 |
| Aug 26, 2026 | 4.79 | 4.79 | 4.50 | 4.50 | 6266.00 |
| Aug 25, 2026 | 4.53 | 4.875 | 4.51 | 4.83 | 20720.00 |
| Aug 24, 2026 | 4.37 | 4.66 | 4.30 | 4.51 | 39264.00 |
| Aug 21, 2026 | 4.53 | 4.725 | 4.35 | 4.44 | 36516.00 |
| Aug 20, 2026 | 4.40 | 4.745 | 4.40 | 4.48 | 11335.00 |
| Aug 19, 2026 | 4.66 | 4.97 | 4.50 | 4.51 | 34180.00 |
| Aug 18, 2026 | 4.50 | 4.696 | 4.44 | 4.52 | 8219.00 |
| Aug 17, 2026 | 4.50 | 4.775 | 4.382 | 4.54 | 10536.00 |
| Aug 14, 2026 | 4.52 | 4.67 | 4.42 | 4.59 | 2206.00 |
| Aug 13, 2026 | 4.54 | 4.72 | 4.54 | 4.575 | 4555.00 |
| Aug 12, 2026 | 4.50 | 4.67 | 4.43 | 4.59 | 6168.00 |
| Aug 11, 2026 | 4.36 | 4.64 | 4.36 | 4.50 | 3704.00 |
| Aug 10, 2026 | 4.36 | 4.67 | 4.25 | 4.32 | 18662.00 |
| Aug 07, 2026 | 4.410 | 4.57 | 4.39 | 4.40 | 6832.00 |
| Aug 06, 2026 | 4.56 | 4.62 | 4.40 | 4.40 | 5431.00 |
| Aug 05, 2026 | 4.59 | 4.730 | 4.59 | 4.61 | 12008.00 |
| Aug 04, 2026 | 4.52 | 4.75 | 4.35 | 4.63 | 38177.00 |
| Aug 03, 2026 | 4.48 | 4.69 | 4.33 | 4.49 | 6958.00 |
| Jul 31, 2026 | 4.53 | 4.616 | 4.47 | 4.47 | 4976.00 |
| Jul 30, 2026 | 4.475 | 4.67 | 4.475 | 4.49 | 5216.00 |
| Jul 29, 2026 | 4.52 | 4.635 | 4.405 | 4.52 | 9853.00 |
| Jul 28, 2026 | 4.470 | 4.59 | 4.42 | 4.57 | 15029.00 |
| Jul 27, 2026 | 4.85 | 4.95 | 4.55 | 4.62 | 29713.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ARS Pharmaceuticals, Inc. | 5.89 |
| ACADIA Pharmaceuticals, Inc. | 29.11 |
| Alnylam Pharmaceuticals, Inc. | 237.10 |
| Anika Therapeutics, Inc. | 21.10 |
| Savara, Inc. | 5.26 |
Price Related Metrics
| PEG Ratio | -0.0083 |
| Price to Book Value | 3.264 |
| Earnings Yield | -250.3% |
| Market Cap | 14.54M |
| PEGY Ratio | -0.0083 |